cabergoline has been researched along with Restless Leg Syndrome in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 16 (72.73) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Akhtar, MF; Akter, R; Al-Harrasi, A; Berrada, M; Bhatia, S; Damiri, F; Ferdous Mitu, J; Kabir, MT; Rahman, MH; Rahman, MS; Saleem, A | 1 |
| Hornyak, M; Kohnen, R; Kriston, L; Riemann, D; Scholz, H; Trenkwalder, C | 1 |
| Connemann, BJ; Gahr, M; Schönfeldt-Lecuona, CJ | 1 |
| George, S; Jones, HB | 1 |
| Aurora, RN; Bista, SR; Casey, KR; Kristo, DA; Lamm, CI; Rosenberg, RS; Rowley, JA; Tracy, SL; Zak, RS | 1 |
| Chaudhuri, KR | 1 |
| Castronovo, C; Ferini-Strambi, L; Oldani, A; Zucconi, M | 1 |
| Benes, H; Heinrich, CR; Kohnen, R; Ueberall, MA | 1 |
| Cuevas, R; Hutchison, K; Jankowiak, J | 1 |
| Rye, DB | 1 |
| Benes, H; Emser, W; Holinka, B; Hornyak, M; Kohnen, R; Leroux, M; Oertel, WH; Peglau, I; Stiasny-Kolster, K; Wessel, K | 1 |
| Aburakawa, Y; Aizawa, H; Enomoto, H; Kikuchi, K; Kimura, T; Makita, Y; Suzuki, Y; Yahara, O | 1 |
| Benes, H; Bodenschatz, R; Cassel, W; Geisler, P; Happe, S; Kohnen, R; Leroux, M; Oertel, WH; Peglau, I; Stiasny-Kolster, K; Warmuth, R | 1 |
| Ausserer, H; Bratti, A; Covi, M; Lochner, P; Marth, R; Nardone, R; Tezzon, F | 1 |
| Benes, H; Grote, L; Happe, S; Högl, B; Kohnen, R; Mathis, J; Saletu-Zyhlarz, GM; Trenkwalder, C | 1 |
| Benes, H; Högl, B; Kohnen, R; Trenkwalder, C | 1 |
| Hornyak, M; Spiegelhalder, K | 1 |
| Gorsler, A; Liepert, J | 1 |
| Miles, AN; Schug, S; Wang, LP | 1 |
| Oertel, WH; Röbbecke, J; Schüler, P; Stiasny, K | 1 |
| Stiasny, K | 1 |
4 review(s) available for cabergoline and Restless Leg Syndrome
| Article | Year |
|---|---|
Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus.
Topics: Bromocriptine; Cabergoline; Diabetes Mellitus, Type 2; Dopamine Agonists; Humans; Hyperprolactinemia; Parkinson Disease; Restless Legs Syndrome | 2022 |
Dopamine agonists for restless legs syndrome.
Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Ergolines; Humans; Levodopa; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Severity of Illness Index | 2011 |
The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline.
Topics: Academies and Institutes; Benzothiazoles; Cabergoline; Carbamates; Dopamine Agents; Ergolines; Evidence-Based Medicine; gamma-Aminobutyric Acid; Humans; Indoles; Levodopa; Nocturnal Myoclonus Syndrome; Pergolide; Peripheral Nervous System Diseases; Pramipexole; Restless Legs Syndrome; Sleep Medicine Specialty; United States; Venous Insufficiency | 2012 |
Restless legs syndrome in older adults.
Topics: Aged, 80 and over; Benzothiazoles; Cabergoline; Circadian Rhythm; Cognition Disorders; Comorbidity; Diagnosis, Differential; Dopamine Agonists; Ergolines; Humans; Indoles; Polysomnography; Pramipexole; Prevalence; Restless Legs Syndrome; Sleep Wake Disorders | 2008 |
11 trial(s) available for cabergoline and Restless Leg Syndrome
| Article | Year |
|---|---|
Cabergoline is an effective single-drug treatment for restless legs syndrome: clinical and actigraphic evaluation.
Topics: Adult; Aged; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Middle Aged; Polysomnography; Restless Legs Syndrome; Single-Blind Method | 2003 |
Long-term safety and efficacy of cabergoline for the treatment of idiopathic restless legs syndrome: results from an open-label 6-month clinical trial.
Topics: Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Middle Aged; Restless Legs Syndrome; Severity of Illness Index; Time; Time Factors | 2004 |
Effective cabergoline treatment in idiopathic restless legs syndrome.
Topics: Aged; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Gastrointestinal Diseases; Hallucinations; Humans; Male; Middle Aged; Nervous System Diseases; Prospective Studies; Restless Legs Syndrome; Severity of Illness Index; Treatment Outcome | 2004 |
Treatment of Japanese restless legs syndrome patients with cabergoline: an open clinical preliminary trial.
Topics: Aged; Aged, 80 and over; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Middle Aged; Restless Legs Syndrome; Treatment Outcome | 2006 |
Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
Topics: Adolescent; Adult; Aged; Cabergoline; Case-Control Studies; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Ergolines; Female; Humans; Male; Middle Aged; Psychometrics; Restless Legs Syndrome; Severity of Illness Index; Statistics, Nonparametric | 2006 |
Cabergoline reverses cortical hyperexcitability in patients with restless legs syndrome.
Topics: Adult; Aged; Brain Diseases; Cabergoline; Dopamine; Dopamine Agonists; Ergolines; Female; Humans; Male; Membrane Potentials; Middle Aged; Motor Cortex; Neural Conduction; Neural Inhibition; Neurons; Pyramidal Tracts; Reaction Time; Restless Legs Syndrome; Synaptic Transmission; Transcranial Magnetic Stimulation; Treatment Outcome | 2006 |
Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial.
Topics: Adult; Aged; Antiparkinson Agents; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Ergolines; Europe; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Restless Legs Syndrome | 2007 |
Augmentation in restless legs syndrome is associated with low ferritin.
Topics: Adult; Cabergoline; Dopamine Agonists; Double-Blind Method; Ergolines; Female; Ferritins; Humans; Levodopa; Male; Patient Dropouts; Prospective Studies; Restless Legs Syndrome; Retrospective Studies; Risk Factors | 2008 |
Influence of cabergoline on motor excitability in patients with restless legs syndrome.
Topics: Aged; Cabergoline; Dopamine Agonists; Electromyography; Ergolines; Evoked Potentials, Motor; Humans; Middle Aged; Motor Cortex; Muscle Contraction; Muscle, Skeletal; Neural Inhibition; Restless Legs Syndrome; Sensory Thresholds; Severity of Illness Index; Time Factors; Transcranial Magnetic Stimulation; Treatment Outcome | 2007 |
Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline--an open clinical trial.
Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Middle Aged; Polysomnography; Quality of Life; Receptors, Dopamine D2; Restless Legs Syndrome; Severity of Illness Index | 2000 |
Clinical data on restless legs syndrome: a dose-finding study with cabergoline.
Topics: Adult; Aged; Cabergoline; Dopamine Agents; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Humans; Male; Restless Legs Syndrome; Surveys and Questionnaires | 2001 |
7 other study(ies) available for cabergoline and Restless Leg Syndrome
| Article | Year |
|---|---|
[Pathological gambling induced by dopamine agonists].
Topics: Antiparkinson Agents; Cabergoline; Dopamine Agonists; Ergolines; Gambling; Humans; Indoles; International Classification of Diseases; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Restless Legs Syndrome | 2011 |
'You never told me I would turn into a gambler': a first person account of dopamine agonist--induced gambling addiction in a patient with restless legs syndrome.
Topics: Cabergoline; Carbidopa; Cognitive Behavioral Therapy; Dopamine Agonists; Drug Combinations; Ergolines; Gambling; Humans; Indoles; Levodopa; Male; Middle Aged; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2011 |
Restless legs syndrome.
Topics: Apomorphine; Cabergoline; Dopamine Agonists; Ergolines; Europe; Humans; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2003 |
Restless legs: do they keep you awake?
Topics: Adult; Aged; Cabergoline; Dopamine; Dopamine Agonists; Ergolines; Humans; Middle Aged; Nocturnal Myoclonus Syndrome; Restless Legs Syndrome; Sleep Deprivation | 2004 |
Relief in sight for restless legs syndrome.
Topics: Cabergoline; Disease Progression; Dopamine Agonists; Ergolines; Genetic Predisposition to Disease; Humans; Restless Legs Syndrome; Treatment Outcome | 2004 |
Tramadol and severe hypertension during anesthesia.
Topics: Aged; Analgesics, Opioid; Anesthesia, General; Cabergoline; Dopamine Agonists; Dopamine Uptake Inhibitors; Drug Interactions; Ergolines; Female; Humans; Hypertension; Restless Legs Syndrome; Selective Serotonin Reuptake Inhibitors; Spinal Fusion; Tramadol | 2008 |
[Cabergolin: new horizons in the therapy of Parkinson diseases].
Topics: Antiparkinson Agents; Cabergoline; Dopamine Agonists; Ergolines; Humans; Parkinson Disease; Restless Legs Syndrome | 1998 |